Sosei
-
- 2012.05.17
- NVA237 Phase III GLOW2 data at American Thoracic Society (ATS) International Conference and Phase II clinical trial update
- 2012.05.15
- Summary of Consolidated Financial Results for the Financial Year ended 31 March 2012 (abridged English version)
- 2012.04.24
- QVA149 ILLUMINATE Phase III COPD study meets primary endpoint and clarification of anticipated timing of US filings for NVA237 and QVA149
- 2012.04.02
- QVA149 phase III COPD studies met primary endpoints
